Professional Services
More than 20 years of sales, reliable quality
International cooperation
International cooperation

For many years, we have adhered to our business in the spirit of professionalism and dedication, worked hard to develop into a high-tech multinational pharmaceutical enterprise, and actively explored markets in Europe, the United States, Asia, Africa and other places around the world.

Domestic agency and distribution
Domestic agency and distribution

Dequan Pharmaceutical has more than 300 marketing and business teams, and has been selected as the first prize of Selling Power in the pharmaceutical industry by Breakthrough magazine. Over the years, it has established a dense sales network in hospitals, clinics, drug stores, cosmetics stores and e-commerce and other medical professional or public channels.

About Dequan Pharmaceutical
Protecting health is a lifelong ambition
Learn More

TC Pharmaceuticals (Jiangsu) Co., Ltd., formerly known as Yungshin Pharmaceutical Industry (Kunshan) Co., Ltd., was a subsidiary of Yungshin Pharmaceutical Group. Founded in December 1994, it was separated from Yungshin Pharmaceutical Group and became an independent company in June 2022. It manufactures and sells tablets, capsules, ointments, injections, and gels. TC Pharmaceuticals (Jiangsu) Co., Ltd. is located in Lujia, Kunshan and covers an area of 94,055 square meters. The manufacturing facility of the company is built in accordance with the current GMP standards. Critical manufacturing equipment, analysis and testing instruments are imported from distinguished manufacturers all over the world, which are fully in line with international standards. In addition, the continuous training and re-education of personnel ensure that the drug manufacturing process aligns with GMP standards.

Latest News
Witness our development together
Good luck in construction!
2023 / 01 / 30
Good luck in construction!
The festive atmosphere of the Spring Festival has not yet dissipated, and Lujiazhen enterprises have switched from the "Spring Festival mode" to the "production mode". Promote production, ensure supply and catch up with orders. Full of riveting power, right to sprint the Year of the Rabbit.
View more
A COVID-19 pharmaceutical manufacturer in Kunshan makes every effort to guarantee supply
2022 / 12 / 17
Recently, the first version of the drug catalog for people infected with COVID-19 was released, in which diclofenac sodium enteric coated sustained-release capsules were included. In order to meet the increasing market demand in the near future, Dequan Pharmaceutical (Jiangsu) Co., Ltd., located in Lujia Town, is busy in its production and packaging workshops. It tries its best to adjust the production line, increase the production capacity, and increase the horsepower to produce diclofenac sodium enteric-coated capsules.
Statement Letter on Yongxin Valsartan Preparation Not Affected by Recall Event
2018 / 07 / 26
Dequan Pharmaceuticals (Jiangsu) Co., Ltd. hereby declares that the drug substance of Gesartan produced by the company (specification: 80mg) is not used by Zhejiang Huahai Pharmaceutical Co., Ltd., so it is not affected by the recall event.
The Food and Drug Administration issued the 6th issue of drug quality announcement
2014 / 12 / 28
Recently, the State Food and Drug Administration issued the latest issue of the drug quality announcement (the sixth issue of the total), announcing the quality and quantity sampling inspection of 3200 batches of 21 varieties of drugs, including acyclovir eye drops, paclitaxel injection, cassia twig tuckahoe pills, lactobacillus dispersible tablets, and compound houttuynia tablets, as well as 45 batches of drugs that failed to meet the standard after inspection.
Yongxin continuously sells new products to the United States through FDA inspection
2014 / 12 / 25
Yongxin Pharmaceuticals (1716) today announced that it passed the FDA factory inspection again with zero 483 missing. After the completion of this factory inspection, the company will continue to sell products in the United States and accept the entrustment of IMPAX and the United States Pharmaceutical Factory. The new products can also be sold in the United States market. It is expected that the company's export sales performance will also have significant growth opportunities.
Join Us
Explore and discover more possibilities of life together

We sincerely invite you to join Dequan Pharmaceutical and join us to make Dequan Pharmaceutical a high-quality enterprise that continues to make contributions to the development of China's medical industry

Learn More
To Top